ROSEMARY MCGONIGLE: Open Payments
NPI 1710258918 · WILLIAMSTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$50 in 3 payments from 3 companies in 2025. Trend: 2023 $33 · 2024 $873 · 2025 $50
Food & beverage: $50
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $17 |
| Ascendis Pharma Endocrinology Inc | 1 | $17 |
| Insulet Corporation | 1 | $16 |
Products named: Ozempic, Yorvipath, Omnipod.
Industry payments across NJ — which companies pay providers there.
